Top PDF Bone marrow fibroblasts in patients with advanced lung cancer
Bone marrow fibroblasts in patients with advanced lung cancer
... low in bone marrow primary cultures from the majority of untreated advanced non-small lung cancer patients (LCP) compared to normal controls ...of bone ...
7
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
... all patients with advanced NSCLC will suffer from progression of their disease, the ultimate goal of palliative chemotherapy is prolongation of OS as well as improvement in patients’ ...
8
Assessment of quality of life in patients with advanced oral cancer who underwent mandibulectomy with or without bone reconstruction
... answers, with scores varying from 0 (worst) to 100 (best), which were assessed in two ways: individ- ually in each domain and the total score for all the domains, calculated as a composite score that ...
7
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
... NSCLCs in patients with European or African ethnicities, 35% of NSCLCs in East Asians, and 50% of NSCLCs in never- smokers are EGFR mutation ...mutations in tumors with ...
11
THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.
... increase in platelet count may promote tumor cells growth and ...role in regulating angio- genesis. The invasiveness of the cancer cells may be en- hanced by the plasma components in stored ...
5
PDF EN Jornal Brasileiro de Pneumologia 5 10 english
... of patients with advanced lung ...50 patients with non-small cell lung cancer (in stages IIIB and IV) and Eastern Cooperative Oncology Group (ECOG) ...
7
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
... Descriptive statistical analysis was performed in this study using SAS 9.1.3. The mean, stan- dard deviation, median, minimum and maximum were used to describe the measurement data. Frequency and percentage were ...
11
Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer.
... heterogeneity with respect to somatic mutations in driver and passenger genes, which may foster tumor adaption and therapeutic failure via Darwinian ...associated with resistance to EGFR-TKIs when ...
7
J. bras. pneumol. vol.36 número5 en v36n5a10
... of patients with advanced lung ...50 patients with non-small cell lung cancer (in stages IIIB and IV) and Eastern Cooperative Oncology Group (ECOG) ...
7
PATHOLOGICAL FRACTURES DUE TO BONE METASTASES FROM LUNG CANCER: RISK FACTORS AND SURVIVAL
... Technetium-99m bone scintigraphy with two additional imaging modalities (plain films and computed tomography or magnetic resonance ...PFs in relation to the time of diagnosis of the primary tumor, ...
6
Potential role of immunotherapy in advanced non-small-cell lung cancer
... that in the intention-to-treat population, the median OS was longer in the atezolizumab group compared with the docetaxel group ...P=0.040). In addition, patients with the ...
10
Endobronchial mucosa invasion predicts survival in patients with small cell lung cancer.
... All patients had a complete history, physical examination, evaluation of performance status and investigations to define the extent of their disease, which included routine hematology and biochemistry, chest ...
7
Transplante de células-tronco hematopoéticas em linfoma Hodgkin.
... factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative ...chemotherapy with autologous bone marrow transplantation in ...
9
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... associated with PFS of advanced NSCLC patients receiving first-line platinum-based ...apparent in subgroup of > 58 years old, male, ever smokers, never smokers, stage IV, histologic type of ...
13
Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer
... 16 Hirsch FR, Varella–Garcia M, Bunn PA Jr, et al. Molecular predictors of outcome with geitinib in a phase III placebocontrolled study in advanced non-small-cell lung cancer. J ...
6
Rev. Saúde Pública vol.41 número2
... of Cancer Therapy – Bone Marrow Transplantation” (FACT-BMT) quality-of-life questionnaire, among bone marrow transplantation ...out in Ribeirão Preto, Southeastern Brazil ...
8
Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients
... metastatic bone disease by skeletal scintigraphy is a classical application of nuclear medicine in cancer ...of bone metastases in patients with lung cancer ...
5
Contents lists available at ScienceDirect
... associated with PFs in patients with bone metastases or lesions from Austria, the Czech Republic, Finland, Greece, Poland, Portugal, Sweden and ...Switzerland. Patients eligible ...
9
Transcriptional profile of fibroblasts obtained from the primary site, lymph node and bone marrow of breast cancer patients
... whether bone marrow mesen- chymal cell gene expression was associated with the pres- ence of occult malignant cells in bone ...two patients with lymph node involvement and ...
10
Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade
... used in men with advanced prostate cancer improving chances of longer ...the in- fluence of androgen blockades on testosterone and luteinizing hormone (LH) values in ...
6
